Author:
Jeong Sung Hoon,Joo Jae Hong,Park Minah,Yun Choa,Kang Soo Hyun,Park Eun-Cheol,Han Yoon Dae,Jang Sung-In
Abstract
Abstract
Purpose
This study investigated the relationship between medical service use and healthcare vulnerability, pre- and post-gastric cancer diagnosis. Differences between healthcare-vulnerable and healthcare-nonvulnerable regions identified inequities that require intervention.
Methods
This cohort study was done using the National Health Insurance claims data of patients diagnosed with gastric cancer between 2004 and 2013. The Position Value for Relative Comparison Index was used to determine whether the patients lived in a healthcare-vulnerable region. Medical service use was classified into annual outpatient treatment, hospitalization days, and emergency treatment. We used a generalized linear model to which the Poisson distribution was applied and compared regional differences in medical service use.
Results
A total of 1797 gastric cancer patients who had survived 5 years post-diagnosis were included in the study, of which 14.2% lived in healthcare-vulnerable regions. The patients in vulnerable regions surviving 5–7 years post-diagnosis had a higher number of outpatient visits than those in nonvulnerable regions. Furthermore, hospitalization days were lesser for patients in vulnerable regions who survived 6 years post-diagnosis than those in nonvulnerable regions; however, this number increased in the seventh year.
Conclusions
Our results suggest that gastric cancer survivors living in healthcare-vulnerable regions have a higher probability of increased medical service use 5 years post-diagnosis compared with patients in nonvulnerable regions, which may significantly increase healthcare disparities over time. Therefore, in the future, additional research is needed to elucidate the causes of the disparities in healthcare use and the results of the differences in health outcomes.
Funder
Ministry of Health & Welfare, Republic of Korea
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Roukos D (2000) Current status and future perspectives in gastric cancer management. Cancer Treat Rev 26:243–255
2. Hamashima C, Goto R (2017) Potential capacity of endoscopic screening for gastric cancer in Japan. Cancer Sci 108:101–107
3. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424
4. Torre LA, Siegel RL, Ward EM, Jemal A (2016) Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiol Prev Biomark 25:16–27
5. Cho YS, Lee SH, So HJ, Kim DW, Choi YJ, Jeon HH (2020) Effect of gastric cancer screening on patients with gastric cancer: a nationwide population-based study. Kor Soc Gastrointest Cancer 8:102–108
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献